Benepali 50 mg, Injektionslösung in einer Fertigspritze

7680663250023 CH-66325 Injektionslösung
Benepali 50 mg, Injektionslösung in einer Fertigspritze
Benepali 50 mg, Injektionslösung in einer Fertigspritze
1 / 2
google

Article details

Package size
2
Selling units
2
Measure
Fertigspritze(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
11/02/2025
Patient information leaflet
Français
11/02/2025
Patient information leaflet
Italien
11/02/2025

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
3.509 MG Substance HBESI
(N/A)
3.509 MG Substance HBESI

Reimbursement information

Public price
CHF 417.30
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/04/2019

Authorization holder

Samsung Bioepis CH GmbH

6005 Luzern

Authorization information

Swissmedic authorization number
66325
Drug name
Benepali, Injektionslösung in einer Fertigspritze
Galenic form
INLFS
ATC Code
L04AB01
Authorization status
Z
Dispensing category
B
First authorization
10/09/2018
Authorization expiration date
31/12/9999
IT Number
07.15.0.
Domain
Human medicine
Field of application
Rheumatoide Arthritis, Psoriasis-Arthritis, Ankylosierende Spondylitis, Plaque-Psoriasis bei Erwachsenen sowie Kindern und Jugendlichen, Juvenile idiopatische Arthritis

Package details

Description (FR)
BENEPALI sol inj 50 mg/ml ser préremp 2 x 1 ml
Description (DE)
BENEPALI Inj Lös 50 mg/ml Fertigspr 2 x 1 ml
Market launch
10/09/2018
Narcotic (BTM)
No

Other package sizes (3)

BENEPALI sol inj 50 mg/ml ser préremp 4 x 1 ml
4 FESP
GTIN: 7680663250016
View
BENEPALI sol inj 25 mg/0.5ml ser pré 4 x 0.5 ml
4 FESP
GTIN: 7680663250030
View
None
8 FESP
GTIN: None
Not in V1